Concepedia

Tesfaye Biftu

TB

48

Publications

3K

Citations

28

H-Index

1975

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Scynexis (United States)

United States Military Academy

Tesfaye Biftu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

PharmacologyMedicineDrug DiscoveryBiochemistryNatural SciencesMedicinal ChemistryPharmacotherapyDrug DevelopmentOrganic ChemistryBioorganic Chemistry

Publications per year

1975–2019

48

Publications

48

Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes

George R. Lankas, Barbara Leiting, Ranabir Sinha Roy et al. · Diabetes · 2005 · 490 citations · Full text

Diabetes Management, Pharmacological Study, Biochemistry +15

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 329 citations

Cardiac Muscle, Cardiovascular Pharmacology, Glucose Homeostasis +23

DETERMINATION OF PUNGENCY DUE TO CAPSICUM BY GAS‐LIQUID CHROMATOGRAPHY

Paul Todd, M. G. BENSINGER, Tesfaye Biftu · Journal of Food Science · 1977 · 184 citations

Flavoromics, Food Analysis, Food Contaminant +17

Epibatidine is a nicotinic analgesic

Changgeng Qian, Tongchuan Li, T. Y. Shen et al. · European Journal of Pharmacology · 1993 · 169 citations

Health Sciences, Pain Medicine, Nicotine +8

Purification and Molecular Characterization of cGMP-dependent Protein Kinase from Apicomplexan Parasites

Anne Gurnett, Paul Liberator, Paula M. Dulski et al. · Journal of Biological Chemistry · 2002 · 168 citations · Full text

Rows per page

1–5 of 48